Certified by Founder
Lodge
SimBioSys, Inc.
start up
United States
- Chicago, Illinois
- 26/10/2021
- Series A
- $15,000,000
SimBioSys is a technology company on a mission to deploy Computational Oncology to transform decision making and patient experience in Cancer Care. By virtualizing cancer, clinicians and patients are empowered with a better understanding of the disease and can assess all available options computationally to truly individualize treatment.
- Industry Biotechnology Research
- Website https://www.simbiosys.com/
- LinkedIn https://www.linkedin.com/company/simbiosys-inc/
TIES | $1,500,000 | (Apr 30, 2026)
Certifyde | $2,000,000 | (Apr 30, 2026)
Parallel Web Systems | $100,000,000 | (Apr 30, 2026)
Skyfire | AI | $11,000,000 | (Apr 30, 2026)
General Analysis | $10,000,000 | (Apr 30, 2026)
Fence | $20,000,000 | (Apr 30, 2026)
Tacalyx GmbH | $12,843,270 | (Apr 30, 2026)
OpenObserve | $10,000,000 | (Apr 30, 2026)
Crazy Mountain | $15,000,000 | (Apr 30, 2026)
Windmill(US) | $12,000,000 | (Apr 29, 2026)
Hypervision Surgical | $22,962,410 | (Apr 29, 2026)
Lighthouse Pharmaceuticals | $12,000,000 | (Apr 29, 2026)